Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Established and Emerging Strategies for Drug Delivery Across the Blood-Brain Barrier in Brain Cancer
Alessandro Parodi, Magdalena Rudzińska, Andrei A. Deviatkin, et al.
Pharmaceutics (2019) Vol. 11, Iss. 5, pp. 245-245
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Nanotechnology and Nanocarrier-Based Drug Delivery as the Potential Therapeutic Strategy for Glioblastoma Multiforme: An Update
Jen‐Fu Hsu, Shih‐Ming Chu, Chen-Chu Liao, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 195-195
Open Access | Times Cited: 106
Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy
Dannielle Upton, Caitlin Ung, Sandra George, et al.
Theranostics (2022) Vol. 12, Iss. 10, pp. 4734-4752
Open Access | Times Cited: 78
Breaking through the glioblastoma micro-environment via extracellular vesicles
Thomas R. Simon, Ellen Jackson, Georgios Giamas
Oncogene (2020) Vol. 39, Iss. 23, pp. 4477-4490
Open Access | Times Cited: 98
Nano-Therapies for Glioblastoma Treatment
Edouard Alphandéry
Cancers (2020) Vol. 12, Iss. 1, pp. 242-242
Open Access | Times Cited: 87
Advances in drug delivery technology for the treatment of glioblastoma multiforme
Gi Doo, Taegyu Kang, Seungmin Baik, et al.
Journal of Controlled Release (2020) Vol. 328, pp. 350-367
Closed Access | Times Cited: 76
Inflammatory Mediators in Glioma Microenvironment Play a Dual Role in Gliomagenesis and Mesenchymal Stem Cell Homing: Implication for Cellular Therapy
Rawan Al‐kharboosh, Karim ReFaey, Montserrat Lara‐Velazquez, et al.
Mayo Clinic Proceedings Innovations Quality & Outcomes (2020) Vol. 4, Iss. 4, pp. 443-459
Open Access | Times Cited: 71
The application of exosomes and Exosome-nanoparticle in treating brain disorders
Soodeh Salarpour, Mahmood Barani, Abbas Pardakhty, et al.
Journal of Molecular Liquids (2022) Vol. 350, pp. 118549-118549
Closed Access | Times Cited: 68
Exosomes: Promising Delivery Tools for Overcoming Blood-Brain Barrier and Glioblastoma Therapy
Seyyed Hossein Khatami, Neda Karami, Mortaza Taheri‐Anganeh, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 8, pp. 4659-4678
Open Access | Times Cited: 40
Drug delivery across the blood-brain barrier for the treatment of pediatric brain tumors – An update
Erica A. Power, Julian S. Rechberger, Sumit Gupta, et al.
Advanced Drug Delivery Reviews (2022) Vol. 185, pp. 114303-114303
Open Access | Times Cited: 39
Modulating the blood–brain tumor barrier for improving drug delivery efficiency and efficacy
Yujun Song, Chuan Hu, Yao Fu, et al.
View (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 38
From cells to organoids: The evolution of blood-brain barrier technology for modelling drug delivery in brain cancer
Estrella Gonzales‐Aloy, Aria Ahmed-Cox, Maria Tsoli, et al.
Advanced Drug Delivery Reviews (2023) Vol. 196, pp. 114777-114777
Closed Access | Times Cited: 27
Advances in the Repurposing and Blood–Brain Barrier Penetrance of Drugs in Pediatric Brain Tumors
Julian S. Rechberger, Stephanie Toll, Subhasree Biswas, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 439-439
Open Access | Times Cited: 1
Diagnosis and Management of Glioblastoma: A Comprehensive Perspective
Vianney Gilard, Abdellah Tebani, Ivana Dabaj, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 4, pp. 258-258
Open Access | Times Cited: 51
Current Status and Perspectives of Protease Inhibitors and Their Combination with Nanosized Drug Delivery Systems for Targeted Cancer Therapy
Magdalena Rudzińska, Cenk Dağlıoğlu, Lyudmila V. Savvateeva, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 9-20
Open Access | Times Cited: 49
A 3D‐Bioprinted Vascularized Glioblastoma‐on‐a‐Chip for Studying the Impact of Simulated Microgravity as a Novel Pre‐Clinical Approach in Brain Tumor Therapy
Giulia Silvani, Carin Basirun, Hanjie Wu, et al.
Advanced Therapeutics (2021) Vol. 4, Iss. 11
Open Access | Times Cited: 43
Nanomedicine for glioblastoma: Progress and future prospects
Imran Khan, Mohammad Hassan Baig, Sadaf Mahfooz, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 172-186
Closed Access | Times Cited: 28
Non-Viral Carriers for Nucleic Acids Delivery: Fundamentals and Current Applications
Sofia Shtykalova, Dmitriy Deviatkin, Svetlana Freund, et al.
Life (2023) Vol. 13, Iss. 4, pp. 903-903
Open Access | Times Cited: 17
Management of Brain Cancer and Neurodegenerative Disorders with Polymer-Based Nanoparticles as a Biocompatible Platform
Mehdi Bazi Alahri, Alhawarin Jibril Ibrahim, Mahmood Barani, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 841-841
Open Access | Times Cited: 16
Meta-analysis of the make-up and properties of in vitro models of the healthy and diseased blood–brain barrier
James G. Shamul, Zhiyuan Wang, Hyeyeon Gong, et al.
Nature Biomedical Engineering (2024)
Closed Access | Times Cited: 6
Enhanced Delivery of Galanin Conjugates to the Brain through Bioengineering of the Anti-Transferrin Receptor Antibody OX26
George Thom, Matthew Burrell, Arsalan S. Haqqani, et al.
Molecular Pharmaceutics (2018) Vol. 15, Iss. 4, pp. 1420-1431
Open Access | Times Cited: 58
Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors
Jessica I. Griffith, Sneha Rathi, Wenqiu Zhang, et al.
Pharmaceutics (2020) Vol. 12, Iss. 12, pp. 1205-1205
Open Access | Times Cited: 48
Antibodies for the Treatment of Brain Metastases, a Dream or a Reality?
Marco Cavaco, Diana Gaspar, Miguel A. R. B. Castanho, et al.
Pharmaceutics (2020) Vol. 12, Iss. 1, pp. 62-62
Open Access | Times Cited: 41
Spatial heterogeneity of nanomedicine investigated by multiscale imaging of the drug, the nanoparticle and the tumour environment
Josanne S. de Maar, Alexandros Marios Sofias, Tiffany Porta Siegel, et al.
Theranostics (2020) Vol. 10, Iss. 4, pp. 1884-1909
Open Access | Times Cited: 41
Development of a human in vitro blood–brain tumor barrier model of diffuse intrinsic pontine glioma to better understand the chemoresistance
Clémence Deligne, Johan Hachani, Sophie Duban‐Deweer, et al.
Fluids and Barriers of the CNS (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 39
Breaching the Blood–Brain Tumor Barrier for Tumor Therapy
Fabrizio Marcucci, Angelo Corti, Andrés J.M. Ferreri
Cancers (2021) Vol. 13, Iss. 10, pp. 2391-2391
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top